<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2023-16-2-108-112</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-1241</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Возможности терапии вторичной эпителиально-эндотелиальной дистрофии роговицы с помощью портативного устройства для локального кросслинкинга коллагена</article-title><trans-title-group xml:lang="en"><trans-title>Therapeutic possibilities for secondary epithelial-endothelial corneal dystrophy using a portable device for local collagen crosslinking</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Яни</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Yani</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елена Владимировна Яни, канд. мед. наук, руководитель отдела инфекционных и аллергических заболеваний глаз,</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Elena V. Yani, Cand. of Med. Sci., head of the department of infectious and allergic eye diseases,</p><p>14/19, Sadovaya Chernogryazskaya St., Moscow, 105062</p></bio><email xlink:type="simple">e_yani@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Селиверстова</surname><given-names>К. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Seliverstova</surname><given-names>K. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ксения Евгеньевна Селиверстова, заведующая отделением инфекционных и  аллергических заболеваний глаз, врач-офтальмолог,</p><p>ул. Садовая-Черногрязская, д. 14/19, Москва, 105062</p></bio><bio xml:lang="en"><p>Ksenia E. Seliverstova, head of the unit of infectious and allergic eye diseases, ophthalmologist,</p><p>14/19, Sadovaya Chernogryazskaya St., Moscow, 105062</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ глазных болезней им. Гельмгольца» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Helmholtz National Medical Research Center of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>01</day><month>07</month><year>2023</year></pub-date><volume>16</volume><issue>2</issue><fpage>108</fpage><lpage>112</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Яни Е.В., Селиверстова К.Е., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Яни Е.В., Селиверстова К.Е.</copyright-holder><copyright-holder xml:lang="en">Yani E.V., Seliverstova K.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/1241">https://roj.igb.ru/jour/article/view/1241</self-uri><abstract><p>Цель работы — оценить эффективность кросслинкинга роговичного коллагена (КРК), проведенного с помощью портативного устройства «Кератолинк», у пациентов с буллезной кератопатией после перенесенной катарактальной хирургии.</p><sec><title>Материал и методы</title><p>Материал и методы. В исследование включены 19 пациентов (19 глаз) в возрасте от 60 до 87 лет с вторичной эпителиально-эндотелиальной дистрофией роговицы, развившейся вследствие катарактальной хирургии. Процедуру КРК выполняли в течение 20 мин. Проведены 3 процедуры с интервалом в 2 дня.</p></sec><sec><title>Результаты</title><p>Результаты. Средняя оценка болевого роговичного синдрома по вербальной шкале боли снизилась с исходной величины 9,0 до 4,5 балла и существенно не менялась при последующих визитах. По данным оптической когерентной томографии средний балл прозрачности роговицы, составлявший перед первой процедурой 2,8, к 20-му дню наблюдения снизился до 1,4 балла. После проведения 3 сеансов КРК буллы продолжали формироваться в течение 3-месячного периода наблюдения только у 3 пациентов (3 глаза, 16 %). Наилучшая корригированная острота зрения через 3 мес после КРК составила 0,07 ± 0,02, что незначительно выше, чем до лечения (0,05 ± 0,03).</p></sec><sec><title>Заключение</title><p>Заключение. Проведение короткого курса процедур ультрафиолетового КРК с помощью портативного устройства «Кератолинк» может быть рекомендовано для паллиативного лечения возрастных пациентов с буллезной кератопатией, развившейся после катарактальной хирургии.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose: to evaluate the effectiveness of corneal collagen crosslinking (CCC) with a portable Keratolink device in patients with bullous keratopathy after cataract surgery.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. 19 patients (19 eyes) aged 60 to 87 with secondary epithelial-endothelial corneal dystrophy, developed due to cataract surgery received three CCC procedures which lasted 20 minutes each, with intervals of 2 days between the procedures.</p></sec><sec><title>Results</title><p>Results. The mean corneal pain score according to verbal pain scale decreased to 4.5 from the initial 9 points and did not change significantly at subsequent visits. Optical coherence tomography data show that before the first procedure, the average corneal transparency score was 2.8 while by the 20th day of observation it fell to 1.4 points. After 3 CCC procedures, bullae continued to form in 3 patients only (3 eyes, 16 %) over the entire 3-month-long observation period. The best corrected visual acuity 3 months after CСC in patients was about 0.07 ± 0.02, which is slightly higher than the initial value (0.05 ± 0.03).</p></sec><sec><title>Conclusion</title><p>Conclusion. A short course of ultraviolet CCC with a portable Keratolink device may be recommended as a palliative treatment for elderly patients with bullous keratopathy developed after cataract surgery.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>вторичная эпителиально-эндотелиальная дистрофия роговицы</kwd><kwd>буллезная кератопатия</kwd><kwd>кросслинкинг роговичного коллагена</kwd><kwd>«Кератолинк»</kwd></kwd-group><kwd-group xml:lang="en"><kwd>secondary epithelial-endothelial corneal dystrophy</kwd><kwd>bullous keratopathy</kwd><kwd>corneal collagen crosslinking</kwd><kwd>Keratolink</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Gonçalves ED, Campos M, Paris F, Gomes JA, Farias CC. Ceratopatia bolhosa: etiopatogênese e tratamento [Bullous keratopathy: etiopathogenesis and treatment]. Arq Bras Oftalmol. 2008 Nov-Dec; 71 (6 Suppl): 61–4. Portuguese. doi: 10.1590/s0004-27492008000700012</mixed-citation><mixed-citation xml:lang="en">Gonçalves ED, Campos M, Paris F, Gomes JA, Farias CC. Ceratopatia bolhosa: etiopatogênese e tratamento [Bullous keratopathy: etiopathogenesis and treatment]. Arq Bras Oftalmol. 2008 Nov-Dec; 71 (6 Suppl): 61–4. Portuguese. doi: 10.1590/s0004-27492008000700012</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Siu GD, Young AL, Jhanji V. Alternatives to corneal transplantation for the management of bullous keratopathy. Current opinion in ophthalmology. 2014 Jul; 25 (4): 347–52. doi: 10.1097/ICU.0000000000000062</mixed-citation><mixed-citation xml:lang="en">Siu GD, Young AL, Jhanji V. Alternatives to corneal transplantation for the management of bullous keratopathy. Current opinion in ophthalmology. 2014 Jul; 25 (4): 347–52. doi: 10.1097/ICU.0000000000000062</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tandon R, Verma K, Vanathi M, et al. Factors affecting eye donation from postmortem cases in a tertiary care hospital. Cornea. 2004; 23: 597–601. doi: 10.1097/01.ico.0000121706.58571.f6</mixed-citation><mixed-citation xml:lang="en">Tandon R, Verma K, Vanathi M, et al. Factors affecting eye donation from postmortem cases in a tertiary care hospital. Cornea. 2004; 23: 597–601. doi: 10.1097/01.ico.0000121706.58571.f6</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Krishnaiah S, Kovai V, Nutheti R, et al. Awareness of eye donation in the rural population of India. Indian journal of ophthalmology. 2004; 52: 73–8.</mixed-citation><mixed-citation xml:lang="en">Krishnaiah S, Kovai V, Nutheti R, et al. Awareness of eye donation in the rural population of India. Indian journal of ophthalmology. 2004; 52: 73–8.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Paris Fdos S, Gonçalves ED, Campos MS., et al. Amniotic membrane transplantation versus anterior stromal puncture in bullous keratopathy: a Рис. 5. Состояние роговицы после трех процедур КРК Fig. 5. Condition of the cornea after three corneal collagen crosslinking procedures comparative study. Br. J. Ophthalmol. 2013 Aug; 97 (8): 980–4. doi: 10.1136/ bjophthalmol-2013-303081</mixed-citation><mixed-citation xml:lang="en">Paris Fdos S, Gonçalves ED, Campos MS., et al. Amniotic membrane transplantation versus anterior stromal puncture in bullous keratopathy: a Рис. 5. Состояние роговицы после трех процедур КРК Fig. 5. Condition of the cornea after three corneal collagen crosslinking procedures comparative study. Br. J. Ophthalmol. 2013 Aug; 97 (8): 980–4. doi: 10.1136/ bjophthalmol-2013-303081</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gomes JA, Haraguchi DK, Zambrano DU, et al. Anterior stromal puncture in the treatment of bullous keratopathy: six-month follow-up. Cornea. 2001 Aug; 20 (6): 570–2. doi: 10.1097/00003226-200108000-00003</mixed-citation><mixed-citation xml:lang="en">Gomes JA, Haraguchi DK, Zambrano DU, et al. Anterior stromal puncture in the treatment of bullous keratopathy: six-month follow-up. Cornea. 2001 Aug; 20 (6): 570–2. doi: 10.1097/00003226-200108000-00003</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Каспаров А.А., Магден Ю., Куренков В.В и др. Эксимер-лазерная фототерапевтическая кератостромэктомия (ФТК) в лечении буллезной хронической кератопатии. Офтальмологический журнал. 1999; 4: 197–201.</mixed-citation><mixed-citation xml:lang="en">Kasparov A.A., Magden Yu., Kurenkov V.V., et al. Excimer laser phototherapeutic keratostromectomy (PTK) in the treatment of bullous chronic keratopathy. Ophthalmological journal. 1999; 4: 197–201 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Фаттахов Б.Т., Никитин Н.А. Способ лечения буллезной кератопатии. Фундаментальные исследования. 2008; 2: 92. http://econf.rae.ru/article/4047 (дата обращения: 10.03.2023)</mixed-citation><mixed-citation xml:lang="en">Fattakhov B.T., Nikitin N.A. Method for the treatment of bullous keratopathy. Fundamental researches. 2008. 2: 92 (In Russ.). http://econf.rae.ru/article/4047 (дата обращения: 10.03.2023)</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Каспаров А.А., Каспарова Е.А., Фадеева Л.Л. и др. Персонализированная клеточная терапия ранней буллезной кератопатии (экспериментальное обоснование и клинические результаты). Вестник офтальмологии. 2013; 129 (5): 53–61.</mixed-citation><mixed-citation xml:lang="en">Kasparov A.A., Kasparova E.A., Fadeeva L.L., et al. Personalized cell therapy for early bullous keratopathy (experimental rationale and clinical results). Vestnik oftal’mologii. 2013; 129 (5): 53–61 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Feinbaum C. A new treatment modality with the Hyper CL soft contact lens. Ophthalmology Times Europe. 2015 May: 1675–881.</mixed-citation><mixed-citation xml:lang="en">Feinbaum C. A new treatment modality with the Hyper CL soft contact lens. Ophthalmology Times Europe. 2015 May: 1675–881.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Arora R, Manudhane A, Saran RK, et al. Role of corneal collagen crosslinking in pseudophakic bullous keratopathy: a clinicopathological study. Ophthalmology. 2013 Dec; 120 (12): 2413–8. doi: 10.1016/j.ophtha.2013.07.038</mixed-citation><mixed-citation xml:lang="en">Arora R, Manudhane A, Saran RK, et al. Role of corneal collagen crosslinking in pseudophakic bullous keratopathy: a clinicopathological study. Ophthalmology. 2013 Dec; 120 (12): 2413–8. doi: 10.1016/j.ophtha.2013.07.038</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Khan MS, Basit I, Ishaq M, et al. Collagen Cross Linking (CXL) in treatment of pseudophakic bullous keratopathy. Pakistan Journal of Medical Sciences. 2016, Jul-Aug; 32 (4): 965–8. doi: 10.12669/pjms.324.10138</mixed-citation><mixed-citation xml:lang="en">Khan MS, Basit I, Ishaq M, et al. Collagen Cross Linking (CXL) in treatment of pseudophakic bullous keratopathy. Pakistan Journal of Medical Sciences. 2016, Jul-Aug; 32 (4): 965–8. doi: 10.12669/pjms.324.10138</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Santhiago MR, Berti TB, Thomaz S, Netto MV. Collagen crosslinking with riboflavin and ultraviolet-A in eyes with pseudophakic bullous keratopathy. Journal of Cataract and Refractive Surgery. 2010 Feb; 36 (2): 273–6. doi: 10.1016/j.jcrs.2009.07.041</mixed-citation><mixed-citation xml:lang="en">Santhiago MR, Berti TB, Thomaz S, Netto MV. Collagen crosslinking with riboflavin and ultraviolet-A in eyes with pseudophakic bullous keratopathy. Journal of Cataract and Refractive Surgery. 2010 Feb; 36 (2): 273–6. doi: 10.1016/j.jcrs.2009.07.041</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Иомдина Е.Н., Сотникова Л.Ф., Гончарова А.В. и др. Применение ультрафиолетового корнеального кросслинкинга при язвах роговицы и других кератопатиях у животных. Российский офтальмологический журнал. 2019; 12 (3): 51–7. https://doi.org/10.21516/2072-0076-2019-12-3-51-57</mixed-citation><mixed-citation xml:lang="en">Iomdina E.N., Sotnikova L.F., Goncharova A.V., et al. Using ultraviolet corneal crosslinking for the treatment of corneal ulcers and other corneal pathologies in animals. Russian ophthalmological journal. 2019; 12 (3): 51–7 (In Russ.). https://doi.org/10.21516/2072-0076-2019-12-3-51-57</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Нероев В.В., Яни Е.В., Иомдина Е.Н. и др. Лечение язв роговицы с помощью локального ультрафиолетового кросслинкинга (экспериментальное исследование). Российский офтальмологический журнал. 2020; 13 (4): 48–57. https://doi.org/10.21516/2072-0076-2020-13-4-48-57</mixed-citation><mixed-citation xml:lang="en">Neroev V.V., Yani E.V., Iomdina E.N., et al. Treatment of corneal ulcers by local ultraviolet crosslinking (an experimental study). Russian ophthalmological journal. 2020; 13 (4): 48–57 (In Russ.). https://doi.org/10.21516/2072-0076- 2020-13-4-48-57</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Яни Е.В., Иомдина Е.Н., Позднякова В.В., Голикова В.А., Селиверстова К.Е. Лечение язв роговицы затяжного течения с помощью ультрафиолетового кросслинкинга роговичного коллагена. Клинические случаи. Российский офтальмологический журнал. 2021; 14 (3): 106–12. https://doi.org/10.21516/2072-0076-2021-14-3-106-112</mixed-citation><mixed-citation xml:lang="en">Yani E.V., Iomdina E.N., Pozdniakova V.V., Golikova V.A., Seliverstova K.E. Treating protracted corneal ulcers with UVA corneal collagen crosslinking: clinical cases. Russian ophthalmological journal. 2021; 14 (3): 106–12 (In Russ.). https://doi.org/10.21516/2072-0076-2021-14-3-106-112</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Плескова А.В., Катаргина Л.А., Иомдина Е.Н. и др. Первые результаты клинического применения ультрафиолетового кросслинкинга роговичного коллагена в лечении язвенных поражений роговицы и трансплантата у детей. Офтальмология. 2022; 19 (3): 692–8. https://doi.org/10.18008/1816-5095-2022-3-692-698</mixed-citation><mixed-citation xml:lang="en">Pleskova A.V., Katargina L.A., Iomdina E.N., et al. First Results of Clinical Application of Ultraviolet Corneal Collagen Crosslinking in the Treatment of Corneal and Graft Ulcers in Children. Ophthalmology in Russia. 2022; 19 (3): 692–8 (In Russ.). https://doi.org/10.18008/1816-5095-2022-3-692-698</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
